Daniel Grosu is the founder of PetDx. PetDx has raised $72M in total funding. Latest round: Series B. Based in San Diego, United States.
Daniel S. Grosu, MD, MBA, is the founder, President, and CEO of PetDx, a veterinary liquid biopsy company he launched in 2019 to revolutionize canine cancer detection. He led the company through a $10 million Series A in 2020 and a $62 million Series B in late 2021, bringing total funding to $72 million before PetDx closed its commercial operations in early 2024. Grosu is based in San Diego, California, and is recognized as an angel investor and genomics industry consultant.
Full founder directory · Investor directory · Company funding database · Fundraising library